Maxcyte (MXCT) Finished Goods (2020 - 2025)
Historic Finished Goods for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $3.3 million.
- Maxcyte's Finished Goods fell 2605.43% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 2605.43%. This contributed to the annual value of $3.9 million for FY2024, which is 3429.81% down from last year.
- Per Maxcyte's latest filing, its Finished Goods stood at $3.3 million for Q3 2025, which was down 2605.43% from $3.5 million recorded in Q2 2025.
- In the past 5 years, Maxcyte's Finished Goods ranged from a high of $6.0 million in Q1 2024 and a low of $2.3 million during Q2 2021
- Its 5-year average for Finished Goods is $3.9 million, with a median of $3.5 million in 2023.
- Its Finished Goods has fluctuated over the past 5 years, first surged by 12145.93% in 2023, then crashed by 4019.23% in 2025.
- Quarter analysis of 5 years shows Maxcyte's Finished Goods stood at $2.5 million in 2021, then increased by 16.25% to $2.9 million in 2022, then skyrocketed by 103.99% to $6.0 million in 2023, then plummeted by 34.3% to $3.9 million in 2024, then decreased by 14.72% to $3.3 million in 2025.
- Its Finished Goods stands at $3.3 million for Q3 2025, versus $3.5 million for Q2 2025 and $3.6 million for Q1 2025.